Integra LifeSciences Reports Third-Quarter 2026 Revenue of $411.18 Million
Net income was $14.85 million and diluted EPS was $0.19, compared with a $5.4 million net loss and a $0.07 per-share loss a year earlier. Revenue was $402.06 million in the prior-year quarter.
Integra LifeSciences Holdings Corp. posted revenue of $411.18 million and net income of $14.85 million for the third quarter of 2026. In the year-earlier quarter, revenue was $402.06 million and the company recorded a net loss of $5.4 million. Diluted earnings per share were $0.19, compared with a loss of $0.07 per share in the prior-year quarter.